-

01:55:01 PM

UTHR Stock News

UTHR - United Therapeutics Corp

09/22/23 2:15 PM

Nasdaq : UTHR

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs

United Therapeutics Corporation, a public benefit corporation, today announced the achievement of two milestones for its xenotransplantation programs in September: the second transplant of a UHeart™ xenoheart into a living person, and a 61- day study of the UThymoKidney™ xenokidney and thymus in a human...

RHEA-AI

neutral

09/12/23 6:00 AM

Nasdaq : UTHR

United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report

United Therapeutics Corporation, a public benefit corporation, today announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of its patients and other...

RHEA-AI

positive

09/01/23 6:00 AM

Nasdaq : UTHR

conferences

United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

United Therapeutics Corporation, a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’ s business during a fireside chat session at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City.

RHEA-AI

neutral

08/02/23 6:00 AM

Nasdaq : UTHR

earnings

United Therapeutics Corporation Reports Second Quarter 2023 Financial Results

United Therapeutics Corporation, a public benefit corporation, today announced its financial results for the quarter ended June 30, 2023. Total revenues in the second quarter of 2023 grew 28% year-over-year to $596.5 million, compared to $466.9 million in the second quarter of 2022.. “I’ m thrilled that United...

RHEA-AI

positive

07/26/23 6:00 AM

Nasdaq : UTHR

conferencesearnings

United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023

United Therapeutics Corporation, announced today that it will report its second quarter 2023 financial results before the market opens on Wednesday, August 2, 2023.. United Therapeutics will host a public webcast Wednesday, August 2, 2023, at 9:00 a.m. Eastern Time. The webcast will be accessible via United...

RHEA-AI

neutral

07/24/23 11:45 AM

Nasdaq : UTHR

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

United Therapeutics Corporation, a public benefit corporation, announced today that the United States Court of Appeals for the Federal Circuit affirmed the district court decision in the patent litigation United Therapeutics brought against Liquidia Technologies, Inc. The Federal Circuit affirmed that...

RHEA-AI

neutral

06/14/23 6:00 AM

Nasdaq : UTHR

United Therapeutics Unveils Net Zero Energy Distribution Center

United Therapeutics Corporation, a public benefit corporation, yesterday unveiled its new net zero energy distribution center located on the company’ s co-headquarters campus in Research Triangle Park, North Carolina. This press release features multimedia. Martine Rothblatt welcomed North Carolina officials, members of the North Carolina General...

RHEA-AI

positive

05/03/23 6:00 AM

Nasdaq : UTHR

United Therapeutics Corporation Reports First Quarter 2023 Financial Results

United Therapeutics Corporation, a public benefit corporation, today announced its financial results for the quarter ended March 31, 2023. Total revenues in the first quarter of 2023 grew 10% year-over-year to $506.9 million, compared to $461.9 million in the first quarter of 2022.. “The hard work and determination...

RHEA-AI

positive

04/26/23 6:00 AM

Nasdaq : UTHR

conferencesearnings

United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023

United Therapeutics Corporation announced today that it will report its first quarter 2023 financial results before the market opens on Wednesday, May 3, 2023. United Therapeutics will host a public webcast Wednesday, May 3, 2023, at 9:00 a.m. Eastern Time. The webcast will be accessible via United Therapeutics'...

RHEA-AI

very positive

04/18/23 6:00 AM

Nasdaq : UTHR

clinical trial

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

United Therapeutics Corporation, a public benefit corporation, today announced that recent research across its development portfolio will be presented at the International Society for Heart and...

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next

UTHR Data

IndustryPharmaceutical Preparation Manufacturing
Websitehttp://www.unither.com/
Security nameUnited Therapeutics Corp
SectorManufacturing
Tags
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
CountryUS

About United Therapeutics Corp

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians